Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units.

MLA

Brüggemann, Finn, et al. “Polypharmacy in Patients with Multiple Sclerosis and the Impact on Levels of Care and Therapy Units.” Frontiers in Neurology, Jan. 2024, pp. 1–6. EBSCOhost, https://doi.org/10.3389/fneur.2023.1330066.

APA

Brüggemann, F., Gross, S., Süße, M., Hok, P., Strauss, S., Ziemssen, T., Frahm, N., Zettl, U. K., & Grothe, M. (2024). Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units. Frontiers in Neurology, 1–6. https://doi.org/10.3389/fneur.2023.1330066

Chicago

Brüggemann, Finn, Stefan Gross, Marie Süße, Pavel Hok, Sebastian Strauss, Tjalf Ziemssen, Niklas Frahm, Uwe K. Zettl, and Matthias Grothe. 2024. “Polypharmacy in Patients with Multiple Sclerosis and the Impact on Levels of Care and Therapy Units.” Frontiers in Neurology, January, 1–6. doi:10.3389/fneur.2023.1330066.